Hvidovre Hospital

The Infectious Diseases department is running a broad portfolio of studies focused on bacterial infections, viral diseases, and critical care. Research here often aims to improve infection control, test better treatment strategies, and strengthen care for hospitalized patients with serious infections.

• Studies in sepsis, bacteremia, and severe hospital-acquired infections
• Trials evaluating shorter or more effective antibiotic treatment approaches
• Research on prevention and management of resistant organisms such as MRSA

Several projects at Hvidovre Hospital also examine how to improve outcomes in acute infection-related illness, including care for patients in intensive care and those with complicated respiratory or bloodstream infections.

A major theme is gastroenterology, especially Crohn’s disease and ulcerative colitis. These trials are designed to assess new therapies, compare treatment strategies, and help patients reach deeper and more durable disease control.

• Research in inflammatory bowel disease focused on remission and symptom control
• Studies testing newer immune-based treatments and combination approaches
• Work aimed at improving long-term disease management and monitoring

The site’s activity in this area reflects a strong interest in improving both short-term response and long-term outcomes for people living with chronic intestinal inflammation.

Another prominent area is respiratory disease, with studies in asthma, chronic obstructive pulmonary disease, bronchiectasis, and viral lung infections. The research is centered on better symptom control, fewer flare-ups, and improved breathing-related quality of life.

• Trials testing new anti-inflammatory and biologic treatments for uncontrolled asthma
• Studies in COPD aimed at reducing exacerbations and hospitalizations
• Research on treatment options for severe viral respiratory illness

These studies combine disease control with practical goals such as reducing medication burden and improving day-to-day respiratory function.

The site also supports research in cardiovascular disease, heart failure, dyslipidemia, obesity, and liver disease such as NASH. Many of these trials focus on lowering risk, improving organ function, and preventing serious complications.

• Studies on heart failure management and recovery after cardiac events
• Trials targeting cholesterol, weight, and metabolic inflammation
• Research on liver health and progression of chronic metabolic liver disease

This mix of studies shows a strong interest in conditions where inflammation, metabolism, and cardiovascular risk overlap.

Clinical trials at the site also cover surgical procedures, pain control, and recovery after orthopedic care. These studies aim to improve comfort, reduce complications, and support safer treatment around operations and fractures.

• Research in hip and knee arthroplasty and postoperative medication management
• Studies on pain relief for fractures and acute musculoskeletal injuries
• Trials assessing ways to reduce bleeding and improve recovery after surgery

The focus is practical and patient-centered, with attention to both immediate treatment effects and recovery outcomes.

A further area of work involves immune system phenomena, viral infections, and care for specific patient groups such as people living with HIV, pregnant women, and patients with recurrent infection-related conditions. These studies often aim to refine prevention, improve treatment response, or support safer care in vulnerable groups.

• Trials in HIV focused on treatment strategies and immune-related outcomes
• Studies on viral illnesses including COVID-19, meningitis, and respiratory viruses
• Research addressing prevention in pregnancy and other higher-risk clinical settings

Together, these projects highlight the site’s interest in immune-mediated disease, infection prevention, and tailored care for patients with complex needs.